Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 41 to 50 of 230 resources
-
One Recovery Bucks BBV Pathway
This best practice resource details the One Recovery Bucks blood borne virus pathway implemented in 2016. The pathway, involving partnership working with the local NHS Trust is much simpler than the previous pathway and is all completed ‘in-house’ at the One Recovery Bucks community drug and alcohol service. The new pathway has resulted in an increase in those who test positive advancing to access treatment from 18% to over 90%.UK 10 Jan 2020 Tools & Templates PDF -
Good practice case study: One Recovery Bucks BBV Pathway
This good practice case study focuses on the One Recovery Bucks drugs service BBV pathway. Implementation of the pathway has seen the proportion of patients who test positive for hepatitis C going on to access treatment increase from 18% to over 90%.UK 10 Jan 2020 Case study PDF -
Shooting Up: Infections among people who inject drugs in the UK, 2018
This December 2019 update to the Shooting Up: Infections among people who inject drugs in the UK, produced by Public Health England, provides updated data to the end of 2018. The report says that there is early evidence for a reduction in chronic hepatitis C prevalence among injecting drug users, but that rates of new infection are unchanged, including amongst individuals who have recently started injecting.UK 20 Dec 2019 Reports & Research PDF -
HCV Action good practice roadshow, South East prisons: Presentations
Presentations from speakers at the HCV Action good practice roadshow held in Woking on November 28th 2019 focusing on best practice in testing and treating people with hepatitis C in prisons. Presentations covered good practice from around England as well as a national overview on the hepatitis C elimination deal from the National Lead for Public Health in secure and detained settings.UK, South East 06 Dec 2019 Training, Reports & Research, Strategy & Planning PDF -
Good practice case study: Pharmacy in Ramsgate giving out daily treatment
This good practice case study looks at the service developed in a collaboration between Courts Pharmacy in Ramsgate, a nurse from East Kent Hospitals University NHS Foundation Trust, and The Forward Trust. Patients who are deemed unlikely to independently manage four weeks of treatment are given the medication in the pharmacy itself so they do not have to look after large numbers of tablets for long periods of time, getting around current legislative barriers preventing the dispensing of hepatitis C treatment from pharmacies.UK, England, South East Case study PDF -
Summary report: Hepatitis C good practice roadshow, West London - September 2019
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England with the West London ODN on 27th September 2019. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.UK, England, Greater London 22 Oct 2019 Training, Reports & Research PDF -
HCV Action and Public Health England hepatitis C good practice roadshow, West London: Presentations
On 27th September 2019, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow with the West London ODN. The event featured presentations on progress in tackling hepatitis C, nationally and locally, and examples of best practice in the prevention, diagnosis, testing and treatment of hepatitis C.UK, England, Greater London 07 Oct 2019 Training, Strategy & Planning PDF -
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 2)
This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) shows the findings from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Of the 66 people who accepted a test, 39% were hepatitis C RNA positive. 78% of those tested also stated they would prefer to receive HCV treatment in their community pharmacy.UK, Greater London Reports & Research PDF -
Public Health England Hepatitis C in the UK 2019 Report
Public Health England published its annual 'Hepatitis C in the UK' report on 13th September 2019. This is the key national reporting document for hepatitis C and monitors the UK's progress towards its goal of eliminating the virus by 2030. This year's report finds that although fewer people are living with chronic hepatitis C than in previous years, the proportion of these people who do not know they are infected has increased to two-thirds (up from half).UK Reports & Research, Strategy & Planning PDF -
Public Health England's Infectious Diseases Strategy 2020-25
Public Health England published 'PHE Infectious Diseases Strategy 2020-25: Addressing urgent threats in the 21st century' in September 2019. The strategy sets out PHE's 10 priorities for infectious diseases over the next five years and how they will achieve these. Of particular relevance to hepatitis C is priority 4, which aims to "Eliminate hepatitis B and C, Tuberculosis and HIV and halt the rise in sexually transmitted infections in our population". The document states PHE will "enable work on detection, surveillance and control of HIV, hepatitis B, C, and TB".UK, England Reports & Research PDF